ArticleThe Journal of clinical investigation2016

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.

Philip L S M Gordts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.